Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
bioRxiv (2021) - Comments
doi: 10.1101/2021.08.06.21261707 

Arjun Puranik, Patrick J. Lenehan, Eli Silvert, Michiel JM Niesen, Juan Corchado-Garcia, John C O'Horo, Abinash Virk, Melanie D. Swift, John Halamka, Andrew D. Badley, AJ Venkatakrishnan, Venky Soundararajan